ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancerEunju Kim, Zheng Chen, Yoon-Jin Kim et al.|Cell Death and Disease|2022Cited by 68